2018;592:2023–31. 16. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. 17. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339:957–9. 18. Pirker CH, Holzmann Klaus, Spiegl-Kreinecker Sabine, Elbling Leonilla, Thal- linger Christiane, Pehamberger Hubert, Micksche Michael, Berger Walter. Chromosomal imbalances in primary and metastatic melanomas: over-rep - resentation of essential telomerase genes. Melanoma Res. 2003;13:483–92. 19. Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henriksson M, Blennow E, et al. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res. 2000;60:6230–5. 20. Taga S, Osaki T, Ohgami A, Imoto H, Yasumoto K. Prognostic impact of tel- omerase activity in non-small cell lung cancers. Ann Surg.